Navigation Links
Oncolytics Biotech Inc. Announces Issuance of 28th U.S. Patent
Date:9/30/2008

ted to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements, except as required by applicable laws.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... -- EntreMed, Inc. (Nasdaq: ENMD ), today ... revenue from sales of Thalomid® during the third ... million. In addition, the Company anticipates a ... fiscal 2009. The difference in estimated and ... reflected in the fourth quarter financial results. ,, ...
(Date:12/11/2009)... December 2009 -- Researchers have discovered a new explanation for ... more excess copies of a certain gene, the more serious ... and it is suspected that it is the amount of ... are being published in the American Journal of Human ... group of Guy Froyen connected to VIB, a life sciences ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer therapeutics company, ... the,US, the Tulane Cancer Center, New Orleans, ... clinical study of Alpharadin in men with,castration-resistant ... has metastasized to the skeleton. , ... SYMptomatic Prostate CAncer) study is a,double-blind, randomized, ...
(Date:12/11/2009)... Inc. (TSX:ONC, NASDAQ: ONCY ) ("Oncolytics" or the ... Warrander to the role of Senior Vice President, ... will be responsible for the execution of the ... Thompson, President and CEO of Oncolytics. "Having reached ... 3 trial examining REOLYSIN in combination with paclitaxel ...
Breaking Biology Technology:EntreMed Reports Receipt of Third Quarter Royalty Payment 2Amount of gene surplus determines severity of mental retardation in males 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3
... Summit run its course? With Summit IV just a few ... will ask about the University of Wisconsin Systems two-day short ... be fair, is wait-and-see. If the fourth economic summit in ... over the past three years and points the way to ...
... Like so many industries tied to the tech sector, the trade ... Things seem to be bouncing back, though, and more and more ... trade shows. , ,Yippee! Good news for trade show booth ... for you and me who have to go and be trade ...
... James Thomson, the Wisconsin scientist who was the first ... years ago, has been named the recipient of the ... Foundation, an independent federal government agency. , ,Annunzio Awards ... world through ingenuity and innovation, and are intended to ...
Other Biology Technology:Wisconsin Economic Summit Aims for a New Lease on Life 2Etiquette at Todays Midwest Technology Trade Show 2Etiquette at Todays Midwest Technology Trade Show 3Stem Cell Pioneer Receives 2003 Frank Annunzio Award 2
(Date:12/13/2009)... CADecember 10, 2009Researchers at The Scripps Research Institute ... single protein from an ancient family of enzymes ... body. In addition to providing guidance for understanding ... a theoretical underpinning for the protein,s possible use ... , The research was published in the December ...
(Date:12/11/2009)... collectively weigh and initiate different survival strategies say they ... decisions that affect their health, wealth and the fate ... week in the early online edition of the journal ... was accomplished when the scientists applied the mathematical techniques ... genes and proteins that colonies of bacteria rely upon ...
(Date:12/11/2009)... New discoveries about the deep ocean,s temperature variability and ... conditions. , The deep ocean is affected more by ... for more accurate predictions of factors such as sea ... surface temperatures have also been found to result in ... results in a faster transport of large quantities of ...
Breaking Biology News(10 mins):Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5New discoveries could improve climate projections 2Solos Endoscopy Inc s MammoView 28TM 29 Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress 5292 1Solos Endoscopy Inc s MammoView 28TM 29 Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress 5292 2Biostar Pharmaceuticals Inc Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray 5288 1Biostar Pharmaceuticals Inc Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray 5288 2Biostar Pharmaceuticals Inc Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray 5288 3Surgeons unanimous consensus 3A Needle biopsy is gold standard for breast cancer diagnosis 59058 1Surgeons unanimous consensus 3A Needle biopsy is gold standard for breast cancer diagnosis 59058 2Surgeons unanimous consensus 3A Needle biopsy is gold standard for breast cancer diagnosis 59058 3
... York, NY, October 30, 2008 Bayhill Therapeutics, Inc., ... the Juvenile Diabetes Research Foundation, the world,s leading charitable ... partnership to support Bayhill,s ongoing Phase I/II human clinical ... immune response that causes type 1 diabetes. , BHT-3021 ...
... for typically include a sense of power, great negotiating skills ... it is not just an outgoing personality and great communication ... group. Previous research has implicated that there is a gender ... leader may depend on the specific situation that a group ...
... D.C. Researchers at Georgetown University Medical Center ... cells become resistant to tamoxifen, the world,s largest-selling breast ... could provide a way to identify tamoxifen users who ... to try another therapy option sooner. , In the ...
Other Biology News:Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration 2Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration 3Gender biases in leadership selection during competitions within and between groups 2Gender biases in leadership selection during competitions within and between groups 3'New' estrogen receptor found to be key player in tamoxifen resistance 2'New' estrogen receptor found to be key player in tamoxifen resistance 3
D4-GDI rabbit polyclonal antibody...
Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....
Rabbit polyclonal to FLIP ( Abpromise for all tested applications). entrezGeneID: 8837 SwissProtID: O15519...
... [EP282Y] to Asparagine synthetase ( ... applications). Antigen: ... residues in the C-terminus of ... Entrez GeneID: 440 ...
Biology Products: